Patent details

EP4135690 Title: (S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING, PREVENTING AND/OR MANAGING A NEUROLOGICAL AND/OR PSYCHIATRIC DISORDER

Basic Information

Publication number:
EP4135690
PCT Application Number:
US2021026953
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217235209
PCT Publication Number:
WO2021211489
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING, PREVENTING AND/OR MANAGING A NEUROLOGICAL AND/OR PSYCHIATRIC DISORDER
French Title of Invention:
(S)-(4,5-DIHYDRO-7 H-THIÉNO[2,3-C]PYRAN-7-YL)-N-MÉTHYLMÉTHANAMINE POUR LE TRAITEMENT, LA PRÉVENTION ET/OU LA GÉSTION D'UNE TROUBLE NEUROLOGIQUE ET/OU PSYCHIATRIQUE
German Title of Invention:
(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMIN ZUR BEHANDLUNG, VORBEUGUNG UND/ODER BEWÄLTIGUNG EINER NEUROLOGISCHEN UND/ODER PSYCHIATRISCHEN STÖRUNG
SPC Number:

Dates

Filing date:
13/04/2021
Grant date:
25/03/2026
EP Publication Date:
22/02/2023
PCT Publication Date:
21/10/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2026
EP B1 Publication Date:
25/03/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/04/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2026
 
 

Name:
Sumitomo Pharma America, Inc.
Address:
84 Waterford Drive, Marlborough, MA 01752, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/04/2026
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BOWEN, Carrie A.
Address:
United States (US)

2

Name:
SYNAN, Colleen M.
Address:
United States (US)

3

Name:
HOPKINS, Seth Cabot
Address:
United States (US)

Priority

1

Priority Number:
202063009595 P
Priority Date:
14/04/2020
Priority Country:
United States (US)

2

Priority Number:
202063039722 P
Priority Date:
16/06/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/381; A61K 45/06; A61P 25/00; A61P 25/16; A61P 25/18; A61P 25/22; A61P 25/28; A61P 25/30;

Publication

European Patent Bulletin

1

Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)

2

Issue number:
202618
Publication date:
29/04/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2027
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/04/2026
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
CLARIVATE IP SERVICES LIMITED
Filing date Document type Number of pages
30/03/2026 Power Of Attorney 1
01/04/2026 Outgoing Correspondence 1